Latest Insider Transactions at Igm Biosciences, Inc. (IGMS)
This section provides a real-time view of insider transactions for Igm Biosciences, Inc. (IGMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IGM Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IGM Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
828
+0.89%
|
-
|
|
Jun 30
2025
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
1,471
+6.21%
|
-
|
|
Jun 30
2025
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
694
+8.8%
|
-
|
|
Jun 30
2025
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,284
+2.31%
|
-
|
|
Jun 30
2025
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,906
+0.15%
|
-
|
|
Jun 30
2025
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
828
+0.03%
|
-
|
|
Jun 30
2025
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
828
+6.12%
|
-
|
|
Jun 16
2025
|
Mary Beth Harler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,522
-0.45%
|
$1,522
$1.2 P/Share
|
|
Jun 16
2025
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,522
-0.84%
|
$1,522
$1.2 P/Share
|
|
Jun 16
2025
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
486
-1.8%
|
$486
$1.2 P/Share
|
|
Jun 16
2025
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
951
-1.29%
|
$951
$1.2 P/Share
|
|
May 14
2025
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,865
-6.46%
|
$1,865
$1.12 P/Share
|
|
Mar 31
2025
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
828
+0.03%
|
-
|
|
Mar 31
2025
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
828
+6.51%
|
-
|
|
Mar 31
2025
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
1,471
+6.62%
|
-
|
|
Mar 31
2025
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
694
+9.64%
|
-
|
|
Mar 31
2025
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,284
+2.37%
|
-
|
|
Mar 31
2025
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
828
+0.9%
|
-
|
|
Mar 31
2025
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,906
+0.15%
|
-
|
|
Mar 14
2025
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,701
-5.56%
|
$1,701
$1.23 P/Share
|
|
Mar 14
2025
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
4,512
-5.78%
|
$4,512
$1.23 P/Share
|
|
Mar 14
2025
|
Mary Beth Harler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,329
-2.11%
|
$7,329
$1.23 P/Share
|
|
Mar 14
2025
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,329
-3.91%
|
$7,329
$1.23 P/Share
|
|
Jan 15
2025
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,122
-3.54%
|
$1,122
$1.7 P/Share
|
|
Dec 31
2024
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+1.89%
|
-
|
|
Dec 31
2024
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
1,452
+20.0%
|
-
|
|
Dec 31
2024
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
2,687
+4.94%
|
-
|
|
Dec 31
2024
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
3,078
+13.77%
|
-
|
|
Dec 31
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
3,988
+0.31%
|
-
|
|
Dec 31
2024
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,734
+0.06%
|
-
|
|
Dec 31
2024
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+13.56%
|
-
|
|
Dec 16
2024
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,708
-0.9%
|
$11,956
$7.48 P/Share
|
|
Dec 16
2024
|
Mary Beth Harler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,708
-0.49%
|
$11,956
$7.48 P/Share
|
|
Dec 16
2024
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,063
-1.34%
|
$7,441
$7.48 P/Share
|
|
Dec 16
2024
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
539
-1.67%
|
$3,773
$7.48 P/Share
|
|
Nov 18
2024
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
66,667
+26.04%
|
-
|
|
Nov 07
2024
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,700
+17.2%
|
-
|
|
Oct 02
2024
|
Mary Beth Harler Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185,000
+34.66%
|
-
|
|
Sep 30
2024
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+15.68%
|
-
|
|
Sep 30
2024
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,734
+0.06%
|
-
|
|
Sep 30
2024
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
2,687
+5.2%
|
-
|
|
Sep 30
2024
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+1.93%
|
-
|
|
Sep 30
2024
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
3,078
+15.96%
|
-
|
|
Sep 30
2024
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
1,452
+25.0%
|
-
|
|
Sep 30
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
3,988
+0.31%
|
-
|
|
Sep 13
2024
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,487
-1.2%
|
$16,357
$11.54 P/Share
|
|
Sep 13
2024
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,487
-0.95%
|
$16,357
$11.54 P/Share
|
|
Sep 13
2024
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
469
-1.8%
|
$5,159
$11.54 P/Share
|
|
Sep 13
2024
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,487
-0.61%
|
$16,357
$11.54 P/Share
|
|
Sep 13
2024
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
3,946
-1.55%
|
$43,406
$11.54 P/Share
|